A subject from a family with ovarian cancer who has developed bilateral medullary carcinoma of the breast at the age of 40 is presented. The family is consistent with dominant inheritance of ovarian cancer and 12 female family members at 12-5%, 25%, and 50% risk, including our case, have undergone bilateral prophylactic oophorectomy and been given hormone replacement therapy. Despite the risk of further primary tumours of the breast our patient chose to have treatment with wide excision and radiotherapy. The implications for screening, prophylaxis, and hormone replacement therapy for this family are discussed.
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Familial ovarian cancer is now a well described entity. There have been around 40 reports of familial aggregations, many of which are consistent with an autosomal dominant mode of inheritance.' There have been even more reports suggesting dominant inheritance of breast cancer23 and others combining the two tumour sites. 4 Formerly, when screening techniques for ovarian cancer were inadequate, prophylactic oophorectomy was widely proposed. Mastectomy for those at risk of breast cancer is a far less popular preventive measure in this country. We present a woman from an apparently dominant ovarian cancer family who opted for oophorectomy and later developed breast cancer.
Case report A 40 year old woman (IV.32, figure) from a family where seven women had developed ovarian cancer presented with a breast lump two years after hysterectomy and bilateral prophylactic oophorectomy. Family members had previously been extensively studied and counselled. Although it would seem logical to offer the option of bilateral mastectomy to a woman from a dominant breast cancer family who develops their first primary, in our experience women are far more likely to agree to losing their ovaries, even when at only 25% risk, than they are to having a prophylactic mastectomy. We are aware of only three women from over 250 families with a history of breast cancer who have opted for mastectomy. This contrasts with 14 cases from five families with ovarian cancer who have had prophylactic oophorectomy. Indeed a further woman (IV.22) is awaiting the operation. A previous study9 reported 28 women from 15 families who chose to have oophorectomy.
There has been little further evidence on the risk of post-oophorectomy intra-abdominal malignancy in ovarian cancer families since it was first reported.9 This may well represent a much lower incidence of this complication than was anticipated. It will be necessary to study a large number of families such as ours to determine the true likelihood of this almost universally fatal malignancy. Without such information it is difficult to counsel women who are considering oophorectomy accurately.
Until a subject opts for oophorectomy, or if they do not, some form of screening should be offered. Pelvic bimanual examination is a poor technique compared to abdominal ultrasound as it identifies the ovaries in only 30% of cases.10 Even abdominal ultrasound can not identify the ovaries in 8 to 13% of subjects at risk, especially when they are overweight. Furthermore, even in a specialist centre, up to 66 women may have a false positive result for every cancer identified.1' These problems can be reduced significantly by using vaginal probes in combination with doppler colour flow imaging. ' 
